TABLE OF CONTENTS
Volume 24, Issue 13 (24 March 2005)
Review
Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention
Ali R Jazirehi and Benjamin Bonavida
Oncogene 24: 2121-2143; doi:10.1038/sj.onc.1208349
Original Papers
Wnt-5a has tumor suppressor activity in thyroid carcinoma
N Kremenevskaja, R von Wasielewski, A S Rao, C Schöfl, T Andersson and G Brabant
Oncogene 24: 2144-2154; advance online publication, February 14, 2005; doi:10.1038/sj.onc.1208370
Functional consequences of G
13 mutations that disrupt interaction with p115RhoGEF
Elda Grabocka and Philip B Wedegaertner
Oncogene 24: 2155-2165; advance online publication, February 14, 2005; doi:10.1038/sj.onc.1208414
Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer
Arthur B McKie, David A Douglas, Sharon Olijslagers, Julia Graham, Mahmoud M Omar, Rakesh Heer, Vincent J Gnanapragasam, Craig N Robson and Hing Y Leung
Oncogene 24: 2166-2174; advance online publication, February 14, 2005; doi:10.1038/sj.onc.1208371
Inactivated MGMT by O 6-Benzylguanine is associated with prolonged G2/M arrest in cancer cells treated with BCNU
Ling Yan, Jon R Donze and Lili Liu
Oncogene 24: 2175-2183; advance online publication, February 7, 2005; doi:10.1038/sj.onc.1208250
p53 deficiency exacerbates pleiotropic mitotic defects, changes in nuclearity and polyploidy in transdifferentiating pancreatic acinar cells
Nathalie Sphyris and David J Harrison
Oncogene 24: 2184-2194; advance online publication, February 14, 2005; doi:10.1038/sj.onc.1208249
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts
Stefano Cairo, Francesca De Falco, Mariateresa Pizzo, Paolo Salomoni, Pier Paolo Pandolfi and Germana Meroni
Oncogene 24: 2195-2203; advance online publication, February 14, 2005; doi:10.1038/sj.onc.1208338
Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors
Bharat Joshi, Dalia Ordonez-Ercan, Piyali Dasgupta and Srikumar Chellappan
Oncogene 24: 2204-2217; advance online publication, February 14, 2005; doi:10.1038/sj.onc.1208206
Cooperation and selectivity of the two Grb2 binding sites of p52Shc in T-cell antigen receptor signaling to Ras family GTPases and Myc-dependent survival
Laura Patrussi, Maria Teresa Savino, Michela Pellegrini, Silvia Rossi Paccani, Enrica Migliaccio, Simon Plyte, Luisa Lanfrancone, Pier Giuseppe Pelicci and Cosima T Baldari
Oncogene 24: 2218-2228; advance online publication, January 31, 2005; doi:10.1038/sj.onc.1208384
Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf−MEK−ERK−AP-1 pathway
Takeshi Hirota, Kenji Irie, Ryoko Okamoto, Wataru Ikeda and Yoshimi Takai
Oncogene 24: 2229-2235; advance online publication, January 31, 2005; doi:10.1038/sj.onc.1208409
Jun proteins modulate the ovary-specific promoter of aromatase gene in ovarian granulosa cells via a cAMP-responsive element
Sagar Ghosh, Yimin Wu, Rong Li and Yanfen Hu
Oncogene 24: 2236-2246; advance online publication, January 31, 2005; doi:10.1038/sj.onc.1208415
Potential molecular mechanism for rodent tumorigenesis: mutational generation of Progression Elevated Gene-3 (PEG-3)
Zao-zhong Su, Luni Emdad, Devanand Sarkar, Aaron Randolph, Kristofer Valerie, Adly Yacoub, Paul Dent and Paul B Fisher
Oncogene 24: 2247-2255; advance online publication, January 17, 2005; doi:10.1038/sj.onc.1208420
Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice
Eva González-Suárez, Christoph Geserick, Juana M Flores and María A Blasco
Oncogene 24: 2256-2270; advance online publication, January 31, 2005; doi:10.1038/sj.onc.1208413
Short Report
Overexpression of human 
TrCP1 deleted of its F box induces tumorigenesis in transgenic mice
Nadia Belaïdouni, Michel Peuchmaur, Christine Perret, Agnes Florentin, Richard Benarous and Corinne Besnard-Guérin
Oncogene 24: 2271-2276; advance online publication, February 14, 2005; doi:10.1038/sj.onc.1208418
